Login
$SMMT
$11.90 +$0.08 (0.68%) After hours

$SMMT 8-K/A SEC Filings

Filed On Filing
24 Nov 2020 8-K/A: Departure/Election of Directors or Officers; Compensation; Other Events

Cambridge, MA, November 23, 2020 – Summit Therapeutics Inc. (NASDAQ: SMMT) announces that Dr. Mahkam “Maky” Zanganeh, DDS, MBA, has been appointed as Chief Operating Officer, effective immediately. Dr. Zanganeh is currently a member of t...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support